Φορτώνει......
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
Improving clinical care for individuals infected with SARS-CoV-2 variants is a global health priority. Small-molecule antivirals like remdesivir (RDV) and biologics such as human monoclonal antibodies (mAbs) have demonstrated therapeutic efficacy against SARS-CoV-2, the causative agent of coronaviru...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
The Author(s).
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8270748/ https://ncbi.nlm.nih.gov/pubmed/34289384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2021.109450 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|